Skip to main content
OpenTrials
Completed

NCT Number: NCT04954053

The Turkish Version of the WUSPI

Wheelchair users frequently experience shoulder pain. It has been determined that in our country, the subjective assessment methods that will help to determine and monitor shoulder pain severity of wheelchair users are limited. The purpose of this study is to adapt the original English version of the Wheelchair Users Shoulder Pain Index into Turkish and to assess its validity and reliability.

Firstly, the original English version of WUSPI was translated into Turkish and culturally adapted, then applied to 100 wheelchair users to investigate the validity of the scale. The reliability of the scale was assessed by internal consistency and test-retest analysis and found a high internal consistency. Validation of WUSPI-Tr was assessed by the concurrent validity method. To establish concurrent validity, WUSPI scores were compared to SPADI and ASES scores by Spearman correlation analysis. There was a positively excellent correlation with SPADI and, negatively excellent correlation with ASES. As a result, it is determined tath the Turkish version of WUSPI-Tr is a valid and reliable tool.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

Gazi University Faculty of Health Sciences Physioteraphy and Rehabilitation Department

Ankara, Çankaya, 06300, Turkey (Türkiye)

About this study

The original version of WUSPI was translated into Turkish via multistep translation rules. It is culturally adapted into Turkish. The semantic equivalence of the new scale was evaluated and the Turkish version of the WUSPI (WUSPI-Tr) has been created. It is applied to 100 wheelchair users to investigate the validity of the scale. People who are at least for 1 year using a manual wheelchair as their primary means of mobility, cognitively unimpaired, literate, and older than 18 years are included in this study. The reliability of the scale was assessed by internal consistency and test-retest analysis. As a result of the analysis, the Cronbach Alfa value was calculated as 0.894, and WUSPI-Tr was found to have high internal consistency. The WUSPI-Tr questionnaire was re-administered to 50 participants for 7 to 14 days for the test-retest method and the results were compared with the Interclass Correlation Coefficient (ICC) method. WUSPI has been found to have high reliability (0.997). Validation of WUSPI-Tr was assessed by the concurrent validity method. To establish concurrent validity, WUSPI scores were compared to SPADI and ASES scores by Spearman correlation analysis. The correlation coefficient of WUSPI-Tr with SPADI is 0.931 and with ASES was -0.812. These results show that there was a positively excellent correlation with SPADI and, negatively excellent correlation with ASES (p < 0,001). As a result, the Turkish version of WUSPI-Tr is a valid and reliable tool.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • accepting the participation
  • using manual wheelchairs as the primary mobility tool for more than a year

Exclusion criteria

  • being illiterate,
  • having cognitive impairment

Treatment and study plan

Primary outcomes

  1. Wheelchair User's Shoulder Pain Index

    Time frame: First Day

    self-reported outcome measure

  2. Shoulder Pain and Disability Index (SPADI)

    Time frame: First Day

    self-reported outcome measure

  3. The Society of American Shoulder and Elbow Surgeons Standardized Shoulder Assessment Form (ASES)

    Time frame: First Day

    self-reported outcome measure

  4. Wheelchair User's Shoulder Pain Index

    Time frame: 2 weeks later

    self-reported outcome measure

Sponsors and collaborators

Lead sponsor

Gazi University

Other

Registry information

Official study title

Validity and Reliability of the Turkish Version of Wheelchair User's Shoulder Pain Index

Important dates

Study start
2017
Primary completion
2017
Study completion
2017
First posted
Jul 8, 2021
Registry last updated
Jul 8, 2021

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.